Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Intellicheck, Inc.Intellicheck Reports 28% Revenue Growth and Net Income Turnaround in Q3 2025
374Water Inc.374Water Inc. Reports 833% Revenue Increase but Faces Growing Net Loss in Q3 2025
STANDARD PREMIUM FINANCE HOLDINGS, INC.Standard Premium Finance Holdings Reports Q3 2025 Revenue Growth and Net Income Changes
INTERPACE BIOSCIENCES, INC.Interpace Biosciences Reports 29% Revenue Decline in Q3 2025
SilverBox Corp IVSilverBox Corp IV Reports Q3 2025 Financial Results and Business Combination Agreement
Sintx Technologies, Inc.SINTX Technologies Reports 74% Revenue Decline in Q3 2025, Net Loss Improves
MICROVISION, INC.MicroVision Reports Q3 2025 Revenue Increase, Strategic Acquisition Planned
WESTWATER RESOURCES, INC.Westwater Resources Reports Increased Net Loss of $9.8 Million for Q3 2025
Lantern Pharma Inc.Lantern Pharma Reports Q3 2025 Financial Results with $4.18 Million Net Loss
Microbot Medical Inc.Microbot Medical Reports $3.6 Million Net Loss in Q3 2025, Increases Liquidity to $6.7 Million
Planet 13 Holdings Inc.Planet 13 Holdings Reports 27.6% Revenue Decline and $44M Net Loss in Q3 2025
Rocket One Inc.Hoth Therapeutics Reports $4.1 Million Net Loss for Third Quarter 2025
Annovis Bio, Inc.Annovis Bio Reports Q3 2025 Financial Results with Reduced Net Loss
Erasca, Inc.Erasca Reports Q3 2025 Financial Results with $30.6 Million Net Loss
Lake Shore Bancorp, Inc. /MD/Lake Shore Bancorp Reports 77.1% Increase in Net Income for Quarter Ending September 30, 2025
authID Inc.authID Inc. Reports Revenue Decline and Increased Net Losses in Q3 2025
EGAIN CorpeGain Corporation Reports 7.8% Revenue Growth in Q1 Fiscal 2026
SOBR Safe, Inc.SOBR Safe Reports 102.1% Revenue Increase but Faces Net Loss in Latest Filing
CalciMedica, Inc.CalciMedica Reports $7.8 Million Net Loss in Q3 2025, Seeks Funding for Clinical Programs
Armata Pharmaceuticals, Inc.Armata Pharmaceuticals Reports $26.7 Million Net Loss in Q3 2025, Seeks Additional Funding
EVOLUTION PETROLEUM CORPEvolution Petroleum Reports Q1 Fiscal 2026 Results with 60% Net Income Decline
Theravance Biopharma, Inc.Theravance Biopharma Reports 19% Revenue Growth and Net Income Turnaround in Q3 2025
European Wax Center, Inc.European Wax Center Reports $54.2 Million Revenue, Net Income Increases 164.4%
Enliven Therapeutics, Inc.Enliven Therapeutics Reports $20.1 Million Net Loss in Q3 2025, Cash Reserves Increase to $477.6 Million
FLUTTER ENTERTAINMENT PLCFlutter Entertainment Reports 17% Revenue Growth but $789M Net Loss in Q3 2025